Arsenal Capital Partners-backed CellCarta buys Biogazelle

Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Biogazelle, a Ghent, Belgium-based specialist in applications to support pharmaceutical research, clinical trials and diagnostic test development.